JB Chemicals & Pharmaceuticals is currently trading at Rs. 125.90, down by 4.05 points or 3.12% from its previous closing of Rs. 129.95 on the BSE.
The scrip opened at Rs. 126.20 and has touched a high and low of Rs. 129.50 and Rs. 119.15 respectively. So far 1,50,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 139.25 on 08-Jan-2014 and a 52 week low of Rs. 70.30 on 26-Mar-2013.
Last one week high and low of the scrip stood at Rs. 132.35 and Rs. 119.15 respectively. The current market cap of the company is Rs. 1,067.00 crore.
The promoters holding in the company stood at 55.87% while Institutions and Non-Institutions held 4.87% and 39.27% respectively.
The company has reported a net loss of Rs 6.47 crore for the third quarter ended December 31, 2013 as compared to net profit of Rs 21.87 crore for the same quarter in the previous year. However, total income of the company has increased by 17.24% at Rs 239.52 crore for quarter under review as compared to Rs 204.29 crore for the quarter ended December 31, 2012.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
The scrip opened at Rs. 126.20 and has touched a high and low of Rs. 129.50 and Rs. 119.15 respectively. So far 1,50,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 139.25 on 08-Jan-2014 and a 52 week low of Rs. 70.30 on 26-Mar-2013.
Last one week high and low of the scrip stood at Rs. 132.35 and Rs. 119.15 respectively. The current market cap of the company is Rs. 1,067.00 crore.
The promoters holding in the company stood at 55.87% while Institutions and Non-Institutions held 4.87% and 39.27% respectively.
The company has reported a net loss of Rs 6.47 crore for the third quarter ended December 31, 2013 as compared to net profit of Rs 21.87 crore for the same quarter in the previous year. However, total income of the company has increased by 17.24% at Rs 239.52 crore for quarter under review as compared to Rs 204.29 crore for the quarter ended December 31, 2012.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
No comments:
Post a Comment